SOUTHWELL DAVID P 4
4 · PTC THERAPEUTICS, INC. · Filed Sep 11, 2025
Insider Transaction Report
Form 4
SOUTHWELL DAVID P
Director
Transactions
- Sale
Common Stock
2025-09-09$58.34/sh−12,000$700,080→ 16,850 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-09-09−12,000→ 0 totalExercise: $30.86Exp: 2026-01-03→ Common Stock (12,000 underlying) - Exercise/Conversion
Common Stock
2025-09-09$30.86/sh+12,000$370,320→ 28,850 total
Footnotes (2)
- [F1]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.31 to $58.45 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F2]Currently exercisable.